2-[(2S)-1-[(Tert-Butoxy)Carbonyl]Pyrrolidin-2-Yl]-1,3-Thiazole-4-Carboxylic Acid

The compound designated 2-[(2S)-1-[(tert-butoxy)carbonyl]pyrrolidin-2-yl]-1,3-thiazole-4-carboxylic acid is supplied as a white to off-white microcrystalline powder, typically with a purity exceeding 98.0% as determined by reversed-phase HPLC at 210 nm. The empirical formula is C₁₃H₁₈N₂O₄S, corresponding to a molecular weight of 298.36 g·mol⁻¹. It is a chiral, non-proteinogenic amino acid surrogate bearing an acid-labile N-Boc protecting group, a pyrrolidine ring that imposes a conformational constraint, and a 1,3-thiazole heterocycle that can participate in metal coordination and π-stacking interactions. The material is hygroscopic; a loss on drying value of ≤1.0% (determined by thermogravimetric analysis at 105 °C under nitrogen flow) is routinely achievable when packaged under argon in septum-sealed borosilicate vials. Differential scanning calorimetry frequently reveals a decomposition endotherm onset above 140 °C without a sharp melting point, which is consistent with the thermal lability of the carbamate functionality.

What Limits Long-Term Storage Stability Under Ambient Bench Conditions?

The N-Boc group undergoes acid-catalyzed cleavage, but even at neutral pH, residual moisture can promote slow deprotection via an autocatalytic pathway that generates carbon dioxide and raises internal package pressure. Accelerated stability studies conducted at 40 °C/75% RH in permeable containers show a purity decay of approximately 2.5% over 14 days, with concurrent formation of 2-[(2S)-pyrrolidin-2-yl]-1,3-thiazole-4-carboxylic acid, the free amine byproduct. Accordingly, the recommended storage condition is −20 °C ± 5 °C in an airtight container protected from light, under which the retest period can extend to 24 months. Exposure to temperatures above 30 °C for cumulative durations exceeding 72 hours during shipment is flagged as a temperature excursion requiring analytical requalification per ICH Q1A(R2) guidance. The free carboxylic acid moiety is susceptible to decarboxylation only under forcing conditions (>180 °C in the presence of copper catalysts), and is not a primary degradation vector during normal handling.

Batch-to-Batch Consistency in Pilot-Plant Campaigns

When manufacture is transferred from a 100 L glass-lined reactor to a 500 L Hastelloy C22 vessel for a 15 kg campaign, the key critical process parameter is the temperature ramp rate during the N-Boc protection of the pyrrolidine nitrogen with di-tert-butyl dicarbonate. Exceeding a ramp of 0.5 K·min⁻¹ in the presence of the thiazole-4-carboxylic acid subunit has been observed, via ReactIR monitoring, to generate a transient mixed anhydride intermediate that can rearrange to an oxazolone, resulting in epimerization at the C2 position of the pyrrolidine ring. The diastereomeric impurity, (2R)-epimer, can reach 3.8–5.2% area under these uncontrolled conditions. By limiting the internal temperature to 22 °C and employing a continuous dosing protocol over 90 minutes, the epimer content is held below 0.15%, as measured by chiral HPLC using a Chiralpak IA-3 column (250 mm × 4.6 mm, 3 µm) with a hexane/ethanol/trifluoroacetic acid eluent system (85/15/0.1) and detection at 254 nm. This level of chiral purity is critical because downstream coupling reactions—for example, in the construction of dipeptidyl protease inhibitor scaffolds—amplify stereochemical mismatches; an epimer content of 0.5% in the building block can lead to a 1.8% yield loss of the desired diastereomer after preparative HPLC separation, as modeled from an observed selectivity factor α of 1.45.

As a heterocyclic building block, the compound is differentiated from widely used N-Boc-L-proline by the replacement of the carboxyl group on the pyrrolidine ring with a 1,3-thiazole-4-carboxylic acid function. In N-Boc-L-proline, the acid is directly attached to the α-carbon of the pyrrolidine, whereas in the title compound, the thiazole acts as a rigid biphenyl isostere that projects the carboxylate donor vector out of the plane of the pyrrolidine, modifying the effective bite angle in bidentate ligand systems. This alteration is quantified by the dihedral angle distribution: molecular mechanics (MMFF94) calculations place the N–C2–C–C(=O) torsion of the Boc-proline system near 120° in its lowest-energy conformer, whereas for the thiazole-inserted analog, the corresponding torsion at the connecting C–C bond between pyrrolidine C2 and thiazole C2 is closer to 0°, leading to a more extended geometry. In practice, the thiazole's nitrogen atom additionally provides a hydrogen-bond acceptor with a pK_a of the conjugate acid estimated at 1.2, which is too weak to compete with backbone amide carbonyls but sufficient to engage in water-mediated contacts in protein binding sites.

Metal-Catalyzed Cross-Coupling at the Thiazole C5 Position

One synthetic elaboration route not available to simple proline derivatives is the direct C–H functionalization of the thiazole ring. Using a catalytic system comprising palladium(II) acetate (5 mol%), triphenylphosphine (10 mol%), and cesium carbonate (2.0 equiv) in N,N-dimethylacetamide at 110 °C, the C5 position undergoes regioselective arylation with aryl iodides. Under these conditions, a substrate scope screen of para-substituted iodobenzenes yielded products in 62–81% isolated yield after 16 hours, with no detectable erosion of the Boc group or epimerization of the pyrrolidine stereocenter as confirmed by chiral SFC. This transformation is not accessible to proline-based synthons and represents a key differentiator when building structure-activity relationship arrays around the eastern portion of the molecule. However, the reaction is sensitive to dissolved oxygen; sparging the solvent with argon for 30 minutes prior to catalyst addition is mandatory to prevent palladium black formation and a drop in conversion below 50%.

The following table compiles the release specification and the typical analytical results derived from a dataset of 12 consecutive production batches manufactured at the 100–500 L scale. All tests reference pharmacopoeial general chapters or equivalent ISO methods where applicable.

Batch Release Specification and Typical Values

Parameter	Method/Techique	Acceptance Criterion	Typical Result (Mean ± SD)
Appearance	Visual inspection	White to off-white powder	White powder
Assay (anhydrous basis)	HPLC, 210 nm	98.0–102.0%	99.4 ± 0.3%
Related substances (total)	HPLC, 210 nm	≤2.0%	0.8 ± 0.2%
Specific optical rotation [α]D20	Polarimetry, c=1.0, MeOH	−85.0° to −95.0°	−90.1 ± 1.5°
Enantiomeric purity	Chiral HPLC (Chiralpak IA-3)	(2R)-epimer ≤0.5%	0.10 ± 0.03%
Water content	Karl Fischer (coulometric)	≤1.0% w/w	0.35 ± 0.15%
Residual solvents	GC-headspace (USP <467>)	IPE ≤500 ppm; THF ≤720 ppm; DMF ≤880 ppm	IPE <100 ppm; THF 120 ± 40 ppm; DMF 210 ± 60 ppm
Residue on ignition	Ph.Eur. 2.4.16	≤0.1%	0.04 ± 0.02%
Heavy metals	ICP-MS (Ph.Eur. 2.4.20)	Pb ≤10 ppm; Cd ≤5 ppm; Hg ≤2 ppm; As ≤2 ppm	All < limit of quantitation

When evaluated in a model amide coupling with L-valine methyl ester hydrochloride using 1-[bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxide hexafluorophosphate (HATU) and N,N-diisopropylethylamine in DMF at 0 °C to room temperature, the isolated yield of the dipeptide surrogate after flash chromatography was 88%, with a diastereomeric excess above 99.5%. This coupling efficiency is comparable to that of the standard N-Boc-protected amino acids under identical activator stoichiometry. However, a key difference emerges during the acidolytic deprotection step: when 4M HCl in dioxane is used to remove the Boc group, the thiazole nitrogen can be partially protonated, altering the solubility and requiring a neutralization step with Amberlyst A-21 ion-exchange resin prior to the subsequent coupling. In contrast, N-Boc-L-proline deprotection does not generate a similarly persistent basic site. Published data for this specific deprotection sequence at multi-kilogram scale is limited, but lab-scale observations confirm that reverse precipitation from methyl tert-butyl ether provides the hydrochloride salt in 95% recovery with an HPLC purity of 97.5% without column chromatography.

Oligomerization Attempts Under Microwave Irradiation

Subjecting the unprotected, Boc-depleted pyrrolidine-thiazole acid to microwave-assisted polycondensation (monomode reactor, 300 W, 180 °C, 1 hour) in the presence of diphenylphosphoryl azide and N-methylmorpholine yielded only low-molecular-weight oligomers (M_n < 800 g·mol⁻¹ by SEC-MALLS). This outcome is attributed to the deactivating effect of the electron-deficient thiazole on the nucleophilicity of the pyrrolidine nitrogen, a feature that contrasts with proline oligomerization where M_n values above 2,000 g·mol⁻¹ are readily attained. This property limits the building block’s utility in homopolymeric peptidomimetic backbones but is not a restriction when it is employed as a terminal capping group or a monomeric scaffold in small-molecule synthesis.

A secondary practical differentiation pertains to the compound’s behavior as a free acid in salt formation screens. When crystalline salt forms are desired for purification or bioavailability modulation, the thiazole carboxylic acid forms stable 1:1 salts with dicyclohexylamine (m.p. 178–181 °C) and tert-butylamine (m.p. 145–148 °C), from which the free acid can be regenerated by partitioning between ethyl acetate and 10% aqueous citric acid. In contrast, N-Boc-L-proline does not yield a crystalline dicyclohexylamine salt under identical conditions, a practical advantage when a high-purity isolation protocol is required without reverse-phase chromatography.

Comparative Physical and Reactivity Attributes with Unprotected Analog

Attribute	2-[(2S)-1-[(tert-butoxy)carbonyl]pyrrolidin-2-yl]-1,3-thiazole-4-carboxylic acid	2-[(2S)-pyrrolidin-2-yl]-1,3-thiazole-4-carboxylic acid (free amine)
Molecular Weight	298.36 g·mol⁻¹	198.24 g·mol⁻¹
LogD7.4 (shake-flask)	1.2	−1.8
Solubility in THF at 25 °C	>50 mg·mL⁻¹	<5 mg·mL⁻¹
Onset of thermal decomposition	140 °C	210 °C
Reactivity with benzyl chloroformate	No reaction (Boc protection intact)	Cbz-derivative formed in 95% yield
Chiral HPLC retention time (relative)	7.8 min (free acid)	4.2 min (as HCl salt)

In the context of drug substance regulatory filings, the compound is frequently treated as a non-commercial protected intermediate. When it is used in a Good Manufacturing Practice (GMP) step, the documentation package must include a residual Boc-amine carryover risk assessment, as the free amine can react with carbonyl electrophiles in subsequent process stages, generating impurities that persist into the active pharmaceutical ingredient. Design of experiments studies varying the extent of in situ Boc cleavage from 0.1% to 2.0% have established a linear correlation between the level of premature deprotection and the formation of a dimeric impurity at RRT 2.34 (relative retention time to API), with a slope of 0.75 (regression r² = 0.993). This data underpins the specification limit of ≤0.5% for the free amine content in the protected intermediate, enforced by a rapid spectrophotometric ninhydrin assay calibrated against the authentic free amine standard at 570 nm.